NEW YORK, Oct. 19, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Cognizant Technology Solutions Corporation (NASDAQ:CTSH) securities between February 25, 2016 and September 30, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/cognizant-technology-solutions-corporation. There is no cost or obligation to you.
According to the complaint, Cognizant Technology officials failed to disclose in its Form 10-K for the fiscal year 2015 improper payments made by the Company for gaining permits and building licenses for some of its facilities in India. The complaint further alleges that the company lacked effective internal controls over financial reporting.
On September 30, 2016, Cognizant Technology announced the September 27, 2016 resignation of company president, Gordon Coburn. In a Form 8-K filed September 30, 2016, Cognizant Technology revealed that it is conducting an internal investigation involving possible violations of the U.S. Foreign Corrupt Practices Act and other applicable laws.
If you suffered a loss in Cognizant Technology you have until December 5, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/cognizant-technology-solutions-corporation.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 



